Hostname: page-component-7c8c6479df-p566r Total loading time: 0 Render date: 2024-03-27T21:36:20.230Z Has data issue: false hasContentIssue false

Massive pericardial effusion caused by “Inflammatory Myofibroblastic Tumour” in a 3-month-old child

Published online by Cambridge University Press:  26 November 2012

Önder Doksöz
Affiliation:
Department of Pediatric Cardiology, Izmir Dr Behcet Uz Children's Hospital, Izmir, Turkey
Timur Mese*
Affiliation:
Department of Pediatric Cardiology, Izmir Dr Behcet Uz Children's Hospital, Izmir, Turkey
Ayşegül Gulden Diniz
Affiliation:
Department of Pediatric Cardiology, Izmir Dr Behcet Uz Children's Hospital, Izmir, Turkey
*
Correspondence to: T. Mese, Department of Pediatric Cardiology, Izmir Dr Behcet Uz Children Hospital, 1417 Street Alsancak, Izmir 35210, Turkey. Tel: +90 23 2489 5656; Fax: +90 23 2489 2315; E-mail: timurmese@yahoo.com

Abstract

Tumours originating from cardiac tissues are rarely encountered during childhood, and fortunately most of these tumours are benign in nature. Inflammatory myofibroblastic tumour, which has unique clinical, pathological, and molecular characteristics, is a relatively new entity compared with previously mentioned tumoural processes originating from the heart. Most of the cardiac intima-media thickness patients are in the age group of 4 months to 17 years. This rarely seen tumoural process has not been subject of any specific research and the prognosis is not well known. Here we present the case of a 3-month-old child who was admitted to our outpatient clinic with massive pericardial effusion and who has shown excellent progress after surgical resection of over 1 year.

Type
Brief Reports
Copyright
Copyright © Cambridge University Press 2012 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gleason, BC, Hornick, JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008; 61: 428437.CrossRefGoogle ScholarPubMed
2. Stark, P, Sandbank, JC, Rudnicki, C, Zahavi, I. Inflammatory pseudotumor of the heart with vasculitis and venous thrombosis. Chest 1992; 102: 18841885.CrossRefGoogle ScholarPubMed
3. Li, L, Cerilli, LA, Wick, MR. Inflammatory pseudotumor (myofibroblastic tumor) of the heart. Ann Diagn Pathol 2002; 6: 116121.CrossRefGoogle ScholarPubMed
4. de Montpréville, VT, Serraf, A, Aznag, H, Nashashibi, N, Planché, C, Dulmet, E. Fibroma and inflammatory myofibroblastic tumor of the heart. Ann Diagn Pathol 2001; 5: 335342.Google Scholar
5. Murdison, KA, Septimus, S, Garola, RE, Pizarro, C. Intracardiac inflammatory myofibroblastic tumor: a unique presentation. Eur J Cardiothorac Surg 2007; 31: 750752.CrossRefGoogle ScholarPubMed
6. Anvari, MS, Soleimani, A, Abbasi, A. Inflammatory myofibroblastic tumor of the right ventricle causing tricuspid valve regurgitation. Tex Heart Inst J 2009; 36: 164167.Google Scholar
7. Vaideeswar, P, Patwardhan, AM, Sathe, PA. Cardiac valvular inflammatory pseudotumor. J Cardiothorac Surg 2008; 3: 53.Google Scholar
8. Attili, SVS, Chandra, CR, Hemant, DK, Bapsy, P, Anupama, G. Retroperitoneal inflammatory myofibroblastic tumor. World J Surg Oncol 2005; 3: 66.Google Scholar
9. Andersen, ND, DiBernardo, LR, Linardic, CM, Camitta, MG, Lodge, AJ. Recurrent inflamatory myofibroblastic tumor of the heart. Circulation 2012; 125: 23792381.Google Scholar